TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA. (Q54347306)

28 May 2018

title

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA. (English)

1 reference

28 May 2018

1 reference

1 reference

3

1 reference

28 May 2018

Carl C Juhlin

4

1 reference

28 May 2018

author name string

Na Wang

1

1 reference

28 May 2018

Tiantian Liu

2

1 reference

28 May 2018

Jan Zedenius

5

1 reference

28 May 2018

Anders Höög

6

1 reference

28 May 2018

Catharina Larsson

7

1 reference

28 May 2018

Dawei Xu

8

1 reference

28 May 2018

language of work or name

English

0 references

publication date

4 June 2014

1 reference

28 May 2018

published in

Cancer

1 reference

28 May 2018

volume

120

1 reference

28 May 2018

issue

19

1 reference

28 May 2018

page(s)

2965-2979

1 reference

28 May 2018

Hallmarks of telomeres in ageing research

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Regulation of the human catalytic subunit of telomerase (hTERT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Human telomerase and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Molecular regulation of telomerase activity in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Telomerase and the endocrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations in familial and sporadic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Highly recurrent TERT promoter mutations in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Frequency of TERT promoter mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

A PCR-based expression signature of malignancy in follicular thyroid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Do benign thyroid nodules have malignant potential? An evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Telomere measurement by quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Differential shortening rate of telomere length in the development of human fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Telomerase expression predicts unfavorable outcome in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

The WHO histological classification of thyroid tumors: a commentary on the second edition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

Specific pattern of RAS oncogene mutations in follicular thyroid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

Thyroid nodular lesion: Analysis of cancer risk based on Kuma Hospital experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

Identifiers

DOI

10.1002/CNCR.28800

1 reference

28 May 2018

1 reference

28 May 2018